Literature DB >> 431682

A new design for randomized clinical trials.

M Zelen.   

Abstract

This paper proposes a new method for planning randomized clinical trials. This method is especially suited to comparison of a best standard or control treatment with an experimental treatment. Patients are allocated into two groups by a random or chance mechanism. Patients in the first group receive standard treatment; those in the second group are asked if they will accept the experimental therapy; if they decline, they receive the best standard treatment. In the analyses of results, all those in the second group, regardless of treatment, are compared with those in the first group. Any loss of statistical efficiency can be overcome by increased numbers. This experimental plan is indeed a randomized clinical trial and has the advantage that, before providing consent, a patient will know whether an experimental treatment is to be used.

Entities:  

Mesh:

Year:  1979        PMID: 431682     DOI: 10.1056/NEJM197905313002203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  193 in total

Review 1.  Contamination in trials: is cluster randomisation the answer?

Authors:  D J Torgerson
Journal:  BMJ       Date:  2001-02-10

2.  To consent or not to consent, that is (not) the (sole) question. "And there is nothing new under the sun". Kohelet (also known as Ecclesiastes), 1:9. Bible.

Authors:  Didier Dreyfuss
Journal:  Intensive Care Med       Date:  2003-12-19       Impact factor: 17.440

3.  Consent for clinical research in the neonatal intensive care unit: a retrospective survey and a prospective study.

Authors:  E Burgess; N Singhal; H Amin; D D McMillan; H Devrome
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2003-07       Impact factor: 5.747

Review 4.  Is intent-to-treat analysis always (ever) enough?

Authors:  Lewis B Sheiner
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

5.  Neonatal research: the parental perspective.

Authors:  B J Stenson; J-C Becher; N McIntosh
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-07       Impact factor: 5.747

Review 6.  Applying evidence to support ethical decisions: is the placebo really powerless?.

Authors:  Franz Porzsolt; Nicole Schlotz-Gorton; Nikola Biller-Andorno; Anke Thim; Karin Meissner; Irmgard Roeckl-Wiedmann; Barbara Herzberger; Renatus Ziegler; Wilhelm Gaus; Ernst Pöppe
Journal:  Sci Eng Ethics       Date:  2004-01       Impact factor: 3.525

Review 7.  Home versus in-patient treatment for deep vein thrombosis.

Authors:  Richard Othieno; Emmanuel Okpo; Rachel Forster
Journal:  Cochrane Database Syst Rev       Date:  2018-01-09

Review 8.  Randomized clinical trials in stroke research.

Authors:  Chul Ahn; Daniel Ahn
Journal:  J Investig Med       Date:  2010-02       Impact factor: 2.895

9.  Randomised trial of telephone intervention in chronic heart failure: DIAL trial.

Authors: 
Journal:  BMJ       Date:  2005-08-20

Review 10.  Adaptive designs for randomized trials in public health.

Authors:  C Hendricks Brown; Thomas R Ten Have; Booil Jo; Getachew Dagne; Peter A Wyman; Bengt Muthén; Robert D Gibbons
Journal:  Annu Rev Public Health       Date:  2009       Impact factor: 21.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.